The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
Doctorate-level psychologists will provide psychotherapy services, advancing Mentavi Health’s mission of making high-quality care available to all via online mental health assessment, diagnosis, and ...